Polyethylene glycol modification: Relevance of improved methodology to tumour targeting

Journal of Drug Targeting

Volumn 3, Issue 5, 1996, Pages 321-340

  Francis, G E ^a   Delgado, C ^a   Fisher, D ^a   Malik, F ^a   Agrawal, A K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Liposomes; Polyethylene glycol; Tumour targeting

Indexed keywords

CANCER ANTIBODY; CYTOTOXIC AGENT; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOSOME; MACROGOL;

CANCER; CHEMICAL MODIFICATION; DRUG TARGETING; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR LOCALIZATION;

EID: 0030047854     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869608996824     Document Type: Review

References (84)

1. Abuchowski, A., van Es, T., Palczuk, N.C., & Davis, F.F. (1977). Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem., 252, 3578-3581.
2. Abuchowski, A., Kazo, G.M, Verhoest Jr, C.R., van Es, T., Kafkewitz, D., Nucci, M.L., Viau, A.T., & Davis, F.F. (1984). Cancer Therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys., 7, 175-186.
3. Albertsson, P.-A. (1986). Partition of Cell Particles and Macromolecules. New York: John Wiley and Sons.
4. Aldwin, L. & Nitecki, D.E. (1987). A water-soluble, monitorable peptide and protein crosslinking agent. Anal. Biochem., 164, 494-501.
5. Allen, T.M, Hansen, C., Martin, F., Redemann, C, & Yau-Young, A. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta, 1066, 29-36.
6. Allen, T.M., Agrawal, A.K., Ahmad, I., Hansen, C.B., & Zalipsky, S. (1994). Antibody-mediated targeting of long-circulating (Stealth) liposomes. J. Lipos. Res., 4, 1-25.
7. Allen, T.M & Chonn, A. (1987). Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett., 223, 42-16.
8. Ash, R.C., Detrick, D.A., & Zanjani, E.D. (1981). Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood, 58, 309-316.
9. Beauchamp, C.O., Gonias, S.L., Menapace, D.P., & Pizzo, S.V. (1983). A new procedure for the synthesis of polyethylene glycol-protein adducts; effects on function, receptor recognition, and clearance of Superoxide dismutase, lactoferrin, and alpha 2-macroglobulin. Anal. Biochem., 131, 25-33.
10. Beddu-Addo, F.K., Klibanov, A.L., & Huang, L. (1994). Effects of polyethyleneglycol-phospholipid conjugates on the phase transition of phosphatidycholines and phosphatidyl-cholesterol mixtures Liposome Research Days Conference Abstract, A-19. (Abstract)
11. Blume, G. & Cevc, G. (1990). Liposomes for the sustained drug release in vivo. Biochim Biophys. Acta, 1029, 91-97.
12. Blume, G. & Cevc, G. (1993). Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta, 1146, 157-168.
13. Carter, M.C. & Meyerhoff, M.E. (1985). Instability of succinyl ester linkages in O2′-monosuccinyl cyclic AMP-protein conjugates at neutral pH. J. Immunol. Methods, 81, 245-257.
14. Delgado, C, Patel, J.N., Francis, G.E., & Fisher, D. (1990). Coupling of poly(ethylene glycol) to albumin under very mild conditions by activation with tresyl chloride: characterization of the conjugate by partitioning in aqueous two-phase systems. Biotechnol. Appl. Biochem., 12, 119-128.
15. Delgado, C., Francis, G.E., & Fisher, D. (1992a). Uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Carrier Syst., 9, 249-304.
16. Delgado, C., Sancho, P., Mendieta, J., & Luque, J. (1992b). Ligand-receptor interactions in affinity cell partitioning. Studies with transferrin covalently linked to monomethoxy(polyethylene glycol) and rat reticulocytes J. Chromatogr., 594, 97-103.
17. Denekamp, J. (1993). Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol., 66, 181-196.
18. Fisher, D. (1989). Liposomes. European Patent EP O 445 131 B1.
19. Forssen, E.A., Coulter, D.M., & Proffitt, R.T. (1992). Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res., 52, 3255-3261.
20. Forssen, E.A. & Ross, M.E. (1994). Daunoxome treatment of solid tumours: preclinical and clinical investigations. J. Lipos. Res., 4, 481-512.
21. Francis, G.E., Delgado, C., & Fisher, D. (1991). PEG-modified proteins. In T.J. Ahem & M. Manning (Eds.), Stability of Protein Pharmaceuticals: in vivo Pathways of Degradation and Strategies for Protein Stabilization (Pharmaceutical Biotechnology, Borchardt, R.T. Ed; vol 3) (pp. 235-263). New York: Plenum.
22. Gabizon, A. & Papahadjopoulos, D. (1992). The role of surface charge and hydrophilic groups on liposome clearance in vivo. Biochim. Biophys. Acta, 1103, 94-100.
23. Gabizon, A.A. (1992). Selective tumor localisation and improved therapeutic index of anthracyclines encapsulated in long circulating liposomes. Cancer Res., 52, 891-896.
24. Goodson, R.J. & Katre, N.V. (1990). Site-directed pegylation of recombinant interleukin-2 at its glycosylation site. Biotechnology, 8, 343-346.
25. Harris, J.M., Yoshinaga, K, Paley, M.S., & Herati, M.R. (1989). New activated PEG derivatives for affinity partitioning. In D. Fisher & I.A. Sutherland (Eds.), Separations Using Aqueous Phase Systems. Applications in Cell Biology and Biotechnology (pp. 203-210). London: Plenum Press
26. Harris, J.M., Dust, J.M., McGill, R.A., Harris, P.A., Edgell, M.J., Sedaghat-Herati, R.M., Karr, L.J., & Donnelly, D.L. (1991). New polyethylene glycols for biomedical applications. In S.W. Shalaby, C.L. McCormick, & G.B. Butler (Eds.), Water-Soluble Polymers Washington, D.C.: American Chemical Society.
27. Harris, J.M. (1992). Poly(etkylene glycol) chemistry. Biotechnical and biomedical applications. New York: Plenum Press.
28. Huang, S.K., Mayhew, E., Gilani, S., Lasic, D.D., Martin, F.J., & Papahadjopoulos, D. (1992). Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res., 52, 6774-6781.
29. Iwashita, Y. & Ajisaka, K. (1981). Blood substitute containing modified hemoglobin. Ajinomoto Co. Incorp, Japan: United States Patent, 4,301,144.
30. Jain, R.K & Baxter, L.T. (1993). Extravasation and interstitial transport in tumours. In K.L Aldus & T.J. Raub (Eds.), Biological barriers to protein delivery (pp. 441-465). New York: Plenum Press.
31. Katre, N.V, Knauf, M.J., & Laird, W.J. (1987). Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. USA, 84, 1487-1491.
32. Kitamura, K., Takahashi, T, Takashina, K., Yamaguchi, T., Noguchi, A., Tsurumi, H., Toyokuni, T., & Hakomori, S. (1990). Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization. Biochem. Biophys. Res. Commun , 171, 1387-1394.
33. Kitamura, K., Takahashi, T., Yamaguchi, T., Noguchi, A., TakashinaK., Tsurumi, H., Inagake, M., Toyokuni, T., & Hakomori, S. (1991). Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy. Cancer Res., 51, 4310-4315.
34. Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y.F., Miyazono, K., Urabe, A., & Takaku, F. (1989). Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol., 140, 323-334.
35. Knusli, C., Delgado, C., Malik, F., Domine, M., Tejedor, M.C., Irvine, A.E., Fisher, D., & Francis, G.E. (1992). Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activity. Br. J. Haematol., 82(4), 654-663.
36. Kuan, C.T., Wang, Q.C., & Pastan, I. (1994). Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner. J. Biol Chem., 269, 7610-7616.
37. Kuhl, T.L., Leckband, D.E., Lasic, D.D., & Israelachvili, J.N. (1994). Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys. J., 66, 1479-1488
38. Leaning, M.S. & Boroujerdi, M.A. (1991). A system for compartmental modelling and simulation Comput. Meth. Progr. Biomed., 35, 71-92.
39. Ledermann, J.A., Begent, R.H., Massof, C., Kelly, A.M., Adam, T., & Bagshawe, K.D. (1991). A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int. J. Cancer, 47, 659-664.
40. Lee, I., Boucher, Y, & Jain, R.K. (1992). Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res., 52, 3237-3240.
41. Lee, I., Boucher, Y., Demhartner, T.J., & Jain, R.K. (1994). Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. Br. J. Cancer, 69, 492-496.
42. Lee, R.J. & Low, P.S. (1994). Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol Chem, 269, 3198-3204.
43. Leonard, M., Neel, J., & Dellacherie; E (1984). Synthesis of monomethoxypolyoxyethylene-bound haemoglobins. Tetrahedron, 40, 1585-1590.
44. Litzinger, D.C., Buiting, A.M., van Rooijen, N., & Huang, L. (1994). Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta, 1190, 99-107.
45. Litzinger, D.C. & Huang, L. (1992). Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolatnine liposomes accumulate in spleen. Biochim. Biophys. Acta, 1127, 249-254.
46. Maeda, H., Kai, Y, & Ono, K. (1989). PEG derivatives, modified peptides and production thereof. EPA 0 340741.
47. Malik, A.B. & Siflinger-Birnboim, A. (1993). Vascular endothelial barrier and its regulation. In K.L. Audus & T.J. Raub (Eds.), Biological barriers to protein delivery (pp. 231-260). New York and London.: Plenum.
48. Malik, E, Delgado, C., Knusli, C., Irvine, A.E., Fisher, D., & Francis, G.E. (1992). Polyethylene glycol (PEG) modified granulocyte-macrophage colony stimulating factor (GM-CSF) with conserved biological activity. Exp. Hematol., 20, 1028-1035.
49. Martin, F., Woodle, M.C., Redemann, C., & Yau-Young, A. (1991). Solid tumor treatment method and composition. Liposome Technology Inc.: World Patent Office WO/91 05546.
50. Maruyama, K., Yuda, T, Okamoto, A., Kojima, S., Suginaka, A., & Iwatsuru, M. (1992). Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phospharidylcholine and cholesterol containing amphipathic poly (ethylene glycol). Biochim. Biophys. Acta, 1128, 44-49.
51. Mayhew, E.G., Lasic, D., Babbar, S., & Martin, F.J. (1992). Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. Int. J. Cancer, 51, 302-309.
52. McGoff, P., Baziotis, A.C., & Maskiewicz, R. (1988). Analysis of polyethylene glycol modified Superoxide dismutase by chromatographic, electrophoretic, light scattering, chemical and enzymatic methods. Chem. Pharm. Bull. Tokyo, 36, 3079-3091.
53. Naylor, P.T., Larsen, H.S., Huang, L., & Rouse, B.T. (1982). In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes. Infect. Immun., 36, 1209-1216.
54. Nilsson, K. & Mosbach, K. (1981). Immobilization of enzymes and affinity ligands to various hydroxyl group carrying supports using highly reactive sulfonyl chlorides. Biochem. Biophys. Res. Commun., 102, 449-457.
55. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang SK., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., & et al., (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88, 1146-11464.
56. Parr, M.J., Ansell, S.M., Choi, L.S., & Cullis, P.R. (1994). Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim. Biophys. Acta, 1195, 21-30.
57. Pizzo, S.V. (1991). Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase. Advanced Drug Delivery Reviews, 6, 153-166.
58. Presant, C.A., Blayney, D., Proffitt, R.T., Turner, A.F., Williams, L.E., Nadel, H.I., Kennedy, P., Wiseman, C., Gala, K., Crossley, R.J., & et al, (1990). Preliminary report: imaging of Kaposi Sarcoma and Lymphoma in AIDS with Indium-111-labelled liposomes. Lancet, 335, 1307-1309.
59. Pyatak, P.S., Abuchowski, A., & Davis, F.F. (1980). Preparation of a polyethylene glycol: Superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity. Res. Commun. Chem. Pathol. Pharmacol, 29, 113-127.
60. Richter, A.W. & Akerblom, E. (1983). Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Int. Arch. Allergy Appl. Immunol, 70, 124-131.
61. Rippe, B. & Haraldsson, B. (1987). Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations. [Review]. Acta Physiol. Scand., 131, 11-428.
62. Sanchez, Y., Ionescu-Matiu, I., Dreesman, G.R., Kramp, W., Six, H.R., HollingerFB., & Melnick, J.L. (1980). Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes. Infect. Immun., 30, 728-733.
63. Sears, B.D. (1983). Synthetic phospholipid compounds and their preparation. Lipid Specialities Inc.: European Patent Office, 0 072 111.
64. Senior, J., Delgado, C., Fisher, D., Tilcock, C., & Gregoriadis, G. (1991). Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta, 1062, 77-82.
65. Silvius, J.R. & Zuckermann, M.J. (1993). Interbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion. Biochemistry, 32, 3153-3161.
66. Snider, J., Neville, C., Yuan, L.C., & Bullock, J. (1992). Characterization of the heterogeneity of polyethylene glycol-modified Superoxide dismutase by Chromatographic and electrophoretic techniques. J. Chromatogr., 599, 141-155.
67. Teske, E., Rutteman, G.R., van Heerde, P., & Misdorp, W. (1990). Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma. Eur. J. Cancer, 26, 891-895.
68. Tilcock, C, Ahkong, G.F., Koenig, S.H., Brown III, R.D., & Fisher, D. (1992). Nuclear magnetic relaxation dispersion and 31p NMR studies of the effect of covlaent modifications of membrane surfaces with polyethylene glycol. Biochem. Biophys. Acta, 1110, 193-198.
69. Tilcock, C., Ahkong, Q.F., & Fisher, D. (1993). Polymer-derivatized technetium 99mTc-labeled liposomal blood pool agents for nuclear medicine applications. Biochim. Biophys. Acta, 1148, 77-84.
70. Tikock, C, Ahkong, Q.F., & Fisher, D. (1994). 99mTc-Labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: Effect of Tin-to-chelate Ratio, chelate content and surface polymer on labeling efficiency and biodistribution behaviour. Nucl. Med. Biol, 21, 89-96.
71. Tsuji, J., Hirose, K., Kasahara, E., Naitoh, M., & Yamamoto, I. (1985). Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase. Int. J. Immunopharmacol, 7, 725-730.
72. Veronese, P.M., Largajolli, R., Boccu, E., Benassi, C.A., & Schiavon, O. (1985). Surface modification of proteins. Activation of monomethoxy-polyethylene glycols by phenylchloroformates and modification of ribonuclease and Superoxide dismutase. Appl. Biochem. Biotectnol., 11, 141-152.
73. Walter, H., Brooks, D.E., & Fisher, D. (Eds.) (1985). Partitioning in Aqueous Two-Phase Systems, Theory, Methods, Uses and Applications to Biotechnology. New York: Academic Press.
74. Walter, MR., Cook, W.J., Ealick, S.E., Nagabhushan, T.L., Trotta, P.P., & Bugg, C.E. (1992). Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. J. Mol. Biol., 224, 1075-1085.
75. Wie, S.I., Wie, C.W., Lee, W.Y., Filion, L.G., Sehon, A.H., & Akerblom, E. (1981). Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method. Int. Arch. Allergy Appl. Immunol., 64, 84-99.
76. Woodle, M.C., Collins, L.R., Sponsler, E., Kossovsky, N., & Papahadjopoulos, D. (1992). Sterically stabilized liposomes. Reduction in electrophoretic mobility but not electrostatic surface potential. Biophys. J., 61, 902-910.
77. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y, Kataoka, K., & Inoue, S. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res., 50, 1693-1700.
78. Yoshimoto, T, Nishimura, H., Saito, Y, Sakurai, K., Kamisaki, Y, Wada, H., Sako, M., Tsujino, G., & Inada, Y. (1986). Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res., 77, 1264-1270.
79. Yoshimoto, T, Ritani, A., Ohwada, K., Takahashi, K., Kodera, Y, Matsushima, A., Saito, Y, & Inada, Y. (1987). Polyethylene glycol derivative-modified cholesterol oxidase soluble and active in benzene. Biochem. Biophys. Res. Commun, 148, 876-882.
80. Yoshinga, K. & Harris, J.M. (1989). Effects of coupling chemistry on the activity of poay(ethylene glycol)-modified alkaline phosphatase. J. Bioactiv. Compatible Polym., 4, 17-24.
81. Yuan, J. (1993). Estimation of variance for AUC in animal studies [letter] J. Pharm. Sci, 82, 761-763.
82. Zalipsky, S. (1990). Active carbonates of polyethylene oxides for modification of polypeptides. WO, 90/13540.
83. Zalipsky, S. (1993). Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjug. Chem., 4, 296-299.
84. Zalipsky, S. & Lee, C. (1992). Use of functionalized polyethylene glycols for modification of polypeptides. In J.M Harris (Ed.), Biomedical Applications of Polyethylene Glycol Chemistry New York: Plenum.